Navigation Links
Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
Date:9/16/2010

rk in March 2008. In the U.S., the MitraClip system is limited by federal law to investigational use only and is not available for sale. The MitraClip system is currently under review for approval by the U.S. Food and Drug Administration.

ABSORB: Nine-month data on 45 patients and six-month data on all 101 patients from the second phase of ABSORB will be presented on Wednesday, Sept. 22. The ABSORB trial is evaluating Abbott's bioresorbable vascular scaffold (BVS), which aims to restore blood flow by opening a clogged vessel and providing support until it is healed. Once the vessel can remain open without the extra support, the BVS is designed to be slowly metabolized and eventually resorbed by the body. Abbott's BVS device is under clinical investigation outside the U.S. The device is currently in development at Abbott Vascular and not available for sale.

As part of its commitment to ongoing medical education, Abbott is providing support for a number of symposia on key topics for interventional cardiologists throughout the conference. In addition, the Abbott booth (#1456) will feature the company's vascular pipeline, as well as resources and programs for physicians and patients.

About XIENCE VAbbott's market-leading XIENCE V drug eluting stent is marketed in the U.S., Europe, Japan and other international markets.

Everolimus, developed by Novartis Pharma AG, is a proliferation signal inhibitor, or mTOR inhibitor, licensed to Abbott by Novartis for use on its drug eluting stents. Everolimus has been shown to inhibit in-stent neointimal growth in the coronary vessels following stent implantation, due to its anti-proliferative properties.

XIENCE V is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (lesions less than or equal to 28 mm) with reference vessel diameters of 2.5 mm to 4.25 mm. Additional information about XIENCE V,
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  The Leukemia & ... million to Valor Biotherapeutics, LLC, a joint venture between ... development, manufacturing, and a Phase I clinical trial for ... outcomes faced by many patients with indolent lymphomas who ... Valor,s protein, IGN002, is a new class ...
(Date:5/22/2013)... 22, 2013  The Lupus Research Institute (LRI) today ... new treatments for lupus nephritis, a serious kidney complication ... The conference launched a new international alliance of researchers ... Network (LNTN). More than 50 of the ... together to focus on two critical questions: 1) Which ...
(Date:5/22/2013)... , May 22, 2013  Milliman, Inc., a premier ... of its 2013 Milliman Medical Index (MMI), which measures ... four receiving healthcare benefits through an employer-sponsored preferred provider ... typical family in 2013 is $22,030. ... prior year on a percentage basis was the lowest ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2
... on the short arm of chromosome 6 (6p21.3), is a ... region is the human equivalent of the Major Histocompatibility Complex ... serve as the backbone of antigen presentation. The Class ... T-cells, are expressed by genes located in the HLA-A, -B ...
... Helen Londe, M.D. Contributing Editor The first human case of ... occurred in Kansas in late June. The CDC has ... being 2005's first documented incidence of the mosquito borne disease ... about 11 kb. It primarily infects birds and mosquitoes, ...
Cached Medicine Technology:The Past, Present and Future of HLA Typing 2The Past, Present and Future of HLA Typing 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4
(Date:5/22/2013)... 22 (HealthDay News) -- Over the next two decades, ... is expected to more than double, topping more than ... The main factor driving the increase: an aging population. ... the American Stroke Association, was published May 22 in ... strain the health care system," Dr. Bruce Ovbiagele, chairman ...
(Date:5/22/2013)... Johns Hopkins researchers report that hospitals may be ... are complicated by preventable bloodstream infections contracted in ... new study, reported online in the American ... that an ICU patient who develops an avoidable ... times more to care for than a similar ...
(Date:5/22/2013)... Phelps Memorial Hospital Center in Sleepy ... Center for individuals who would like to be screened ... is the deadliest form of cancer for both men and ... from lung cancer than from breast, colon and prostate cancer ... survival rates. It is well established that routine mammography ...
(Date:5/22/2013)... Hurricane preparation isn’t just about stocking up on ... Insurance is reminding everyone to review their insurance ... “An important part of hurricane preparedness is reviewing your ... president at Amica Insurance. “The best time to review ... storm.” , Flood damage is not covered under standard ...
(Date:5/22/2013)... Space Girl Organics is excited to announce ... I Talk to Strangers Miracle Run/Walk . The 5K ... Park in Cocoa, FL. The event aims to “create miracles” ... movement. , As a sponsor, Space Girl Organics is organizing ... event. Additionally, they are providing bananas for runners and donating ...
Breaking Medicine News(10 mins):Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2
... WHAT: The community is invited to attend a ... of Momentum in Science, part of a four-part documentary, ... Thursday, May 7 ... distinguished panel of local, internationally renowned, ...
... Attorney A. Brian Albritton announces the filing of ... concerning WellCare Health Plans, Inc. (WellCare). The Information ... employees, in an elaborate scheme to defraud the ... Corporation ("Healthy Kids" or FHKC) program of approximately ...
... and commitment to education about this rare disease -- ... on Monday, May 11, 2009 at the Mondrian Hotel ... with National Eosinophil Awareness Week, the American Partnership for ... and the Jonas Group,s Ned Specktor as 2009-2010 Honorary ...
... Calif., May 5 As of May 5, 2009, ... of Influenza A (H1N1) infection in 21 different countries. ... virus continues to evolve, the Centers for Disease Control ... Interim Guidance on Specimen Collection and Processing for Patients ...
... HOME, Ark., May 5 Baxter Regional Medical Center ... patient satisfaction , in the National ... Emergency Department. They have also reached number one in ... in Missouri. Compirion Healthcare Solutions, a hospital process improvement ...
... Antioxidant-Rich Spices and Herbs Can Enhance Your Daily Routine ... is here, motivating many people to eat more healthfully ... overhaul and change in routine can seem overwhelming. That,s ... focus to small, achievable steps is a concept that,s ...
Cached Medicine News:Health News:HBO, the Arizona Alzheimer's Consortium and the Alzheimer's Association, Desert Southwest Chapter Present a Free Advance Screening of THE ALZHEIMER'S PROJECT: Momentum In Science 2Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 2Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 3Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 4Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 5Health News:The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education 2Health News:The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education 3Health News:CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus 2Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 2Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 3Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 4Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 5Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 6Health News:Simple Steps Toward a Healthy Lifestyle 2Health News:Simple Steps Toward a Healthy Lifestyle 3